Bloomberg
Nasdaq Biotech Index on Pace for Biggest Gain in 6 Weeks
Bloomberg's Abigail Doolittle takes a look at the performance of pharmaceutical stocks. She speaks on "Bloomberg Markets." (Source: Bloomberg)
Bloomberg
Why T. Rowe Price Is Suing Valeant Now
Aug. 18 -- T. Rowe Price sued Valeant alleging top executives used a secret network of pharmacies, deceptive pricing, reimbursement practices and accounting tricks to hide its branded drugs from generic competition and artificially...
Bloomberg
Trump to Talk Drug Pricing With Pharma CEOs
Jan.31 -- President Donald Trump welcomes pharmaceutical CEOs to a White House meeting today on drug pricing as he seeks drug price negotiations between the government and drug makers. Bloomberg's Jennifer Epstein reports on "Bloomberg...
Bloomberg
Bayer's Baumann Says on Track With Monsanto Filings
Apr.27 -- Werner Baumann, chief executive officer at Bayer, discusses first-quarter earnings, the Monsanto deal and his outlook for Covestro. He speaks on "Bloomberg Markets: European Open."
Bloomberg
U.K.'s Hammond Warns No-Deal Brexit Holds Large Fiscal Consequences
Aug.24 -- Allie Renson, head of Europe and public policy at Institute of Directors, discusses the warning from U.K. Chancellor of the Exchequer Philip Hammond that a no-Brexit deal could put a 80 billion pound dent in the nation's...
Bloomberg
Sanofi China Chair Says Beijing Sending Good Message
Nov.07 -- French drugmaker Sanofi says it's encouraged by the stance Xi Jinping has taken on opening China's market, but is wary of Beijing's recent regulatory changes. China Chair Jean-Christophe Pointeau speaks to Bloomberg's Stephen...
Bloomberg
J&J Predicts Slower Sales Growth in 2019
Jan.22 -- Johnson & Johnson said sales growth will be slower in 2019, despite beating analyst's expectations for the fourth quarter. Bloomberg Opinion columnist Brooke Sutherland reports on "Bloomberg Markets: The Open." Her opinions are...
Bloomberg
AbbVie Shares Tumble After $63 Billion Allergan Deal
Jun.25 -- AbbVie Inc. has agreed to buy Allergan Plc in a $63 billion deal that unites the rival drug makers in a bid for growth. Bloomberg's Drew Armstrong reports on "Bloomberg Markets."
Bloomberg
Four Opioid Distributors Settle With Ohio Counties for $260 Million
Oct.21 -- The three largest U.S. drug wholesalers, plus a generic drug manufacturer, reached a deal worth more than $250 million to settle the first federal trial over the companies' role in the U.S. opioid epidemic. Bloomberg's Drew...
Bloomberg
Trump Says Politics Could Be Holding Back Covid Plasma Treatment
Aug.19 -- President Donald Trump alleged that U.S. health regulators may be delaying the emergency authorization of blood plasma to treat coronavirus patients until after the election to hurt him politically, offering no substantiation...
Bloomberg
Darkest Days of Covid Crisis Are Ahead: Maryland's Governor
Jan.27 -- Maryland Governor Larry Hogan, a Republican, talks about how his state is responding to the Covid-19 pandemic. He appears on the latest episode of "The David Rubenstein Show: Peer-to-Peer Conversations." The interview was...
Bloomberg
Mitsubishi Chemical CEO on Strategy, Gender Gap in Japan
Apr.29 -- Jean-Marc Gilson, the newly-arrived chief executive officer of Mitsubishi Chemical Holdings Corp., shares his strategy to return the company to profitability. The 90-year-old Japanese chemical giant that has interests in...
Bloomberg
Sinovac CEO Yin Responds to Controversies Surrounding CoronaVac
May.12 -- CoronaVac, which was developed by China's Sinovac Biotech Ltd., has turned into one of the world's most used Covid-19 vaccines, but questions about it's efficiency have lingered. It posted lower efficacy rate than the vaccines...
Bloomberg
NSIA CEO on Future Investment Plans for Nigeria's Sovereign Wealth Fund
Mar.17 -- Uche Orji, Nigeria Sovereign Investment Authority, CEO discusses NSIA future investment plans. He speaks with Manus Cranny on "Bloomberg Daybreak: Middle East."
Bloomberg
Pfizer CEO Says Allocation of Covid Pill Will Be Fair
Pfizer CEO Albert Bourla discusses the manufacturing and distribution plans for its Covid-19 pill, which the drugmaker says reduced hospitalizations and deaths in high-risk patients by 89%. He speaks on "Bloomberg Markets: The Close."
Bloomberg
China 'Definitely' Needs 2nd Covid Booster Dose: CanSino Biologics CEO
Yu Xuefeng, chief executive officer of CanSino Biologics Inc., a Tianjin, China-based drugmaker that's rolling out a vaccine that can be inhaled, discusses the supply-demand outlook in the country. He speaks with David Ingles on...
Bloomberg
Ebola Vaccine May Be Available in January: W.H.O.
Oct. 21 -- Bloomberg's Erik Schatzker reports on today's top news stories on Market Makers.
Bloomberg
Bill Ackman Won Both Ways on Allergan Deal: George
Nov. 17 -- Bill George, former chairman and chief executive officer at Medtronic, Columbia Universitys Fabio Savoldelli, and Bloomberg's Drew Armstrong examine the timeline of the $66 billion deal that finds Actavis acquiring Allergan...
Bloomberg
Sanofi Board Votes Unanimously to Oust CEO Viehbacher
Oct. 29 -- Sanofi has removed Chris Viehbacher as chief executive officer, ending a six-year tenure that saw moves that caused tension with the companys board and French politicians. Bloomberg Intelligences Sam Fazeli reports on On the...
Bloomberg
Deals in 2014: Why $800B Is Still Pending
Dec. 26 -- As we get ready to enter the new year, there are still $800 billion in corporate mergers and acquisitions that arent done yet.
Bloomberg
The Top Ten Stocks for Thursday, Sept. 25
Sept. 25 -- Bloomberg's Betty Liu, Scarlet Fu and Olivia Sterns report on today's ten most important stocks including Ford, Mannkind and Nike. They speak on Bloomberg Television's ""In The Loop."" (Source: Bloomberg)
Bloomberg
Pfizer Said to Have Approached Actavis About Deal
Sept. 24 -- Bloomberg's Hans Nichols reports on Pfizer approaching Actavis to express interest in an acquisition. He speaks to Mark Barton on ""Countdown."" (Source: Bloomberg)
Bloomberg
Novartis 3Q Core EPS $1.37; Est. $1.32
Oct. 28 ""Novartis, the world's biggest drugmaker by sales, posted third-quarter earnings. Bloomberg's Mark Barton reports on ""Countdown."" (Source: Bloomberg)